CELECOXIB
- Product NDC
- 70934-469
- 11-digit product format
- 709340469
- Labeler code
- 70934
- Product ID
- 70934-469_f1623236-0228-1788-e053-2a95a90a53ce
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Celecoxib
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Denton Pharma, Inc. DBA Northwind Pharmaceuticals
- Application
- ANDA204776
- Marketing category
- ANDA
- Marketing start
- 2019-12-04
- Marketing end
- 2023-07-31
- Substance
- CELECOXIB
- Active strength
- 100 mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 70934-469-30 | 70934046930 | 30 CAPSULE in 1 BOTTLE, PLASTIC (70934-469-30) | 30 capsule | 2020-01-30 | 0000-00-00 | No | No | Current |
| 70934-469-60 | 70934046960 | 60 CAPSULE in 1 BOTTLE, PLASTIC (70934-469-60) | 60 capsule | 2019-12-04 | 0000-00-00 | No | No | Current |